Grove, a San Francisco, CA-based clinical trial management and intelligence company, raised $4.9M in Seed funding.
The round was led by A*, with participation from Afore Capital, LifeX Ventures, Pear VC, Upfront Ventures, and angels including Ajit Baid, Chloe Yoo, Phuc Truong, Till Pieper, among others.
The company intends to use the funds to continue scaling its team and product to redefine clinical trials from siloed operations into participant-centered ecosystems driven by real-time data.
Led by CEO Tran Le, Grove AI empowers clinical trials with its AI-powered participant relationship management (PRM) platform, delivering actionable insights and accelerating critical trial processes. It also empowers research organizations to streamline operations, engage participants, and accelerate life-saving therapies.
At the core is Grace, a multilingual, 24/7 AI clinical research agent. Grace prescreens participants, schedules appointments, and coordinates logistics and follow-ups. By powering a dynamic feedback loop, Grace enables research teams to adapt rapidly, reduce staff burnout, and conduct trials with efficiency and precision.
FinSMEs
08/01/2025